Global Cannabidiol (CBD)

Cannabidiol (CBD) Comprehensive Study by Type (Recreational, Medicinal, Synthetic.), Application (CBD For Food & beverage, CBD Cosmetics & personal Care, CBD Pharmaceutical, Other), Variants (Genus, Cannabis, Species, Strains), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores, Others), Form (CBD Processed Oil, CBD Distillate, CBD Isolated) Players and Region - Global Market Outlook to 2028

Cannabidiol (CBD) Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Cannabidiol (CBD) Market Scope?
Cannabidiol (CBD) is a chemical in the Cannabis sativa plant, also known as cannabis or hemp. Cannabidiol can be taken internally in multiple ways, including by inhaling cannabis smoke or vapor, orally, and as an aerosol spray into the cheek. Cannabidiol is an active cannabinoid used as an adjunctive treatment for the management of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome and symptomatic relief of moderate to severe neuropathic pain or other painful conditions, like cancer. Cannabidiol (CBD) for health and wellness purposes is strong due to its therapeutic characteristics are the driver of market growth.

Influencing Trend:
Increase In Research And Development Activities In The Biopharma Sector

Market Growth Drivers:
High Demand for Cannabis-Related Pharmaceutical Products., Rising Geriatric Population In Need Of Treatment for Chronic Diseases and Growing Demand for Cannabis Testing Products from Luxury Cannabis Products

Challenges:
CBD products are very expensive.

Restraints:
Many Side Effect Of CBD Oil and Cause's Major Side Impact

Opportunities:
CBD's medicinal applications are expanding.

The Cannabidiol (CBD) market study is being classified by Type (Recreational, Medicinal and Synthetic.), by Application and major geographies with country level break-up.

Global CBD Market is a fragmented market due to the presence of a large number of established competitors. The key players are highly focused on developing and innovating new strategies to maintain their market position and customer base. The companies are also planning strategic activities like partnerships, collaboration, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge.

INSYS Therapeutics, INC (United States), EPIDOLEX (United Kingdom), Night food holding (United States), pivot pharmaceuticals INC (Canada), marijuana company of America (United States), ENDOCA (United States), Cannoid, LLC (United States), Folium Biosciences (United States), Elixinol (United States) and NuLeaf Naturals, LLC (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Cannabidiol (CBD) market by Type, Application and Region.

On the basis of geography, the market of Cannabidiol (CBD) has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their Development Strategies
In March 2021, is pleased to announce that it has entered into a binding agreement for its subsidiary to acquire all of the issued share capital of CannaCare Health GmbH (CannaCare), a company incorporated in Germany (Proposed Transaction). The vendors of CannaCare are Mr. Frank Otto, Ms. Annette-Rosa Oplesch, and an entity associated with Mr. Michael Oplesch (Vendors). The Proposed Transaction is subject to the satisfaction of certain conditions precedent, the details of which are set out below.
In October 2021, Elixinol, announces its partnership with CBD Emporium, a leading retail specialty CBD chain with corporate-owned and franchise locations throughout the country. Elixinol’s product line, featuring multiple formats and unique formulations, including tinctures, liposomes, capsules, and topicals, are available at all CBD Emporium’s retail locations and its online store. CBD Emporium has also expanded its business to include franchise opportunities to entrepreneurs


Key Target Audience
Regulatory bodies, Including government agencies and NGO, Commercial research and development (RandD) institutions, Government organizations, research organizations, and consulting firms, Trade associations and industry bodies, End-use industries and Others

Cannabidiol (CBD) Market Study: Important Years
AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Major Highlights of Market Study

Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Cannabidiol (CBD) Market.

Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.

Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Cannabidiol (CBD) industry is examined with reference relevant market sectors and sub-sectors.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Recreational
  • Medicinal
  • Synthetic.
By Application
  • CBD For Food & beverage
  • CBD Cosmetics & personal Care
  • CBD Pharmaceutical
  • Other
By Variants
  • Genus
  • Cannabis
  • Species
  • Strains

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores
  • Others

By Form
  • CBD Processed Oil
  • CBD Distillate
  • CBD Isolated

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Demand for Cannabis-Related Pharmaceutical Products.
      • 3.2.2. Rising Geriatric Population In Need Of Treatment for Chronic Diseases
      • 3.2.3. Growing Demand for Cannabis Testing Products from Luxury Cannabis Products
    • 3.3. Market Challenges
      • 3.3.1. CBD products are very expensive.
    • 3.4. Market Trends
      • 3.4.1. Increase In Research And Development Activities In The Biopharma Sector
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cannabidiol (CBD), by Type, Application, Variants, Distribution Channel, Form and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Cannabidiol (CBD) (Value)
      • 5.2.1. Global Cannabidiol (CBD) by: Type (Value)
        • 5.2.1.1. Recreational
        • 5.2.1.2. Medicinal
        • 5.2.1.3. Synthetic.
      • 5.2.2. Global Cannabidiol (CBD) by: Application (Value)
        • 5.2.2.1. CBD For Food & beverage
        • 5.2.2.2. CBD Cosmetics & personal Care
        • 5.2.2.3. CBD Pharmaceutical
        • 5.2.2.4. Other
      • 5.2.3. Global Cannabidiol (CBD) by: Variants (Value)
        • 5.2.3.1. Genus
        • 5.2.3.2. Cannabis
        • 5.2.3.3. Species
        • 5.2.3.4. Strains
      • 5.2.4. Global Cannabidiol (CBD) by: Distribution Channel (Value)
        • 5.2.4.1. Hospital Pharmacies
        • 5.2.4.2. Retail Pharmacies
        • 5.2.4.3. Online Stores
        • 5.2.4.4. Others
      • 5.2.5. Global Cannabidiol (CBD) by: Form (Value)
        • 5.2.5.1. CBD Processed Oil
        • 5.2.5.2. CBD Distillate
        • 5.2.5.3. CBD Isolated
      • 5.2.6. Global Cannabidiol (CBD) Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Cannabidiol (CBD) (Volume)
      • 5.3.1. Global Cannabidiol (CBD) by: Type (Volume)
        • 5.3.1.1. Recreational
        • 5.3.1.2. Medicinal
        • 5.3.1.3. Synthetic.
      • 5.3.2. Global Cannabidiol (CBD) by: Application (Volume)
        • 5.3.2.1. CBD For Food & beverage
        • 5.3.2.2. CBD Cosmetics & personal Care
        • 5.3.2.3. CBD Pharmaceutical
        • 5.3.2.4. Other
      • 5.3.3. Global Cannabidiol (CBD) by: Variants (Volume)
        • 5.3.3.1. Genus
        • 5.3.3.2. Cannabis
        • 5.3.3.3. Species
        • 5.3.3.4. Strains
      • 5.3.4. Global Cannabidiol (CBD) by: Distribution Channel (Volume)
        • 5.3.4.1. Hospital Pharmacies
        • 5.3.4.2. Retail Pharmacies
        • 5.3.4.3. Online Stores
        • 5.3.4.4. Others
      • 5.3.5. Global Cannabidiol (CBD) by: Form (Volume)
        • 5.3.5.1. CBD Processed Oil
        • 5.3.5.2. CBD Distillate
        • 5.3.5.3. CBD Isolated
      • 5.3.6. Global Cannabidiol (CBD) Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Cannabidiol (CBD) (Price)
      • 5.4.1. Global Cannabidiol (CBD) by: Type (Price)
  • 6. Cannabidiol (CBD): Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. INSYS Therapeutics, INC (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. EPIDOLEX (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Night food holding (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pivot pharmaceuticals INC (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Marijuana company of America (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ENDOCA (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cannoid, LLC (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Folium Biosciences (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Elixinol (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. NuLeaf Naturals, LLC (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Cannabidiol (CBD) Sale, by Type, Application, Variants, Distribution Channel, Form and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Cannabidiol (CBD) (Value)
      • 7.2.1. Global Cannabidiol (CBD) by: Type (Value)
        • 7.2.1.1. Recreational
        • 7.2.1.2. Medicinal
        • 7.2.1.3. Synthetic.
      • 7.2.2. Global Cannabidiol (CBD) by: Application (Value)
        • 7.2.2.1. CBD For Food & beverage
        • 7.2.2.2. CBD Cosmetics & personal Care
        • 7.2.2.3. CBD Pharmaceutical
        • 7.2.2.4. Other
      • 7.2.3. Global Cannabidiol (CBD) by: Variants (Value)
        • 7.2.3.1. Genus
        • 7.2.3.2. Cannabis
        • 7.2.3.3. Species
        • 7.2.3.4. Strains
      • 7.2.4. Global Cannabidiol (CBD) by: Distribution Channel (Value)
        • 7.2.4.1. Hospital Pharmacies
        • 7.2.4.2. Retail Pharmacies
        • 7.2.4.3. Online Stores
        • 7.2.4.4. Others
      • 7.2.5. Global Cannabidiol (CBD) by: Form (Value)
        • 7.2.5.1. CBD Processed Oil
        • 7.2.5.2. CBD Distillate
        • 7.2.5.3. CBD Isolated
      • 7.2.6. Global Cannabidiol (CBD) Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Cannabidiol (CBD) (Volume)
      • 7.3.1. Global Cannabidiol (CBD) by: Type (Volume)
        • 7.3.1.1. Recreational
        • 7.3.1.2. Medicinal
        • 7.3.1.3. Synthetic.
      • 7.3.2. Global Cannabidiol (CBD) by: Application (Volume)
        • 7.3.2.1. CBD For Food & beverage
        • 7.3.2.2. CBD Cosmetics & personal Care
        • 7.3.2.3. CBD Pharmaceutical
        • 7.3.2.4. Other
      • 7.3.3. Global Cannabidiol (CBD) by: Variants (Volume)
        • 7.3.3.1. Genus
        • 7.3.3.2. Cannabis
        • 7.3.3.3. Species
        • 7.3.3.4. Strains
      • 7.3.4. Global Cannabidiol (CBD) by: Distribution Channel (Volume)
        • 7.3.4.1. Hospital Pharmacies
        • 7.3.4.2. Retail Pharmacies
        • 7.3.4.3. Online Stores
        • 7.3.4.4. Others
      • 7.3.5. Global Cannabidiol (CBD) by: Form (Volume)
        • 7.3.5.1. CBD Processed Oil
        • 7.3.5.2. CBD Distillate
        • 7.3.5.3. CBD Isolated
      • 7.3.6. Global Cannabidiol (CBD) Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Cannabidiol (CBD) (Price)
      • 7.4.1. Global Cannabidiol (CBD) by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cannabidiol (CBD): by Type(USD Million)
  • Table 2. Cannabidiol (CBD) Recreational , by Region USD Million (2017-2022)
  • Table 3. Cannabidiol (CBD) Medicinal , by Region USD Million (2017-2022)
  • Table 4. Cannabidiol (CBD) Synthetic. , by Region USD Million (2017-2022)
  • Table 5. Cannabidiol (CBD): by Application(USD Million)
  • Table 6. Cannabidiol (CBD) CBD For Food & beverage , by Region USD Million (2017-2022)
  • Table 7. Cannabidiol (CBD) CBD Cosmetics & personal Care , by Region USD Million (2017-2022)
  • Table 8. Cannabidiol (CBD) CBD Pharmaceutical , by Region USD Million (2017-2022)
  • Table 9. Cannabidiol (CBD) Other , by Region USD Million (2017-2022)
  • Table 10. Cannabidiol (CBD): by Variants(USD Million)
  • Table 11. Cannabidiol (CBD) Genus , by Region USD Million (2017-2022)
  • Table 12. Cannabidiol (CBD) Cannabis , by Region USD Million (2017-2022)
  • Table 13. Cannabidiol (CBD) Species , by Region USD Million (2017-2022)
  • Table 14. Cannabidiol (CBD) Strains , by Region USD Million (2017-2022)
  • Table 15. Cannabidiol (CBD): by Distribution Channel(USD Million)
  • Table 16. Cannabidiol (CBD) Hospital Pharmacies , by Region USD Million (2017-2022)
  • Table 17. Cannabidiol (CBD) Retail Pharmacies , by Region USD Million (2017-2022)
  • Table 18. Cannabidiol (CBD) Online Stores , by Region USD Million (2017-2022)
  • Table 19. Cannabidiol (CBD) Others , by Region USD Million (2017-2022)
  • Table 20. Cannabidiol (CBD): by Form(USD Million)
  • Table 21. Cannabidiol (CBD) CBD Processed Oil , by Region USD Million (2017-2022)
  • Table 22. Cannabidiol (CBD) CBD Distillate , by Region USD Million (2017-2022)
  • Table 23. Cannabidiol (CBD) CBD Isolated , by Region USD Million (2017-2022)
  • Table 24. South America Cannabidiol (CBD), by Country USD Million (2017-2022)
  • Table 25. South America Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 26. South America Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 27. South America Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 28. South America Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 29. South America Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 30. Brazil Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 31. Brazil Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 32. Brazil Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 33. Brazil Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 34. Brazil Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 35. Argentina Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 36. Argentina Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 37. Argentina Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 38. Argentina Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 39. Argentina Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 40. Rest of South America Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 41. Rest of South America Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 42. Rest of South America Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 43. Rest of South America Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 44. Rest of South America Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 45. Asia Pacific Cannabidiol (CBD), by Country USD Million (2017-2022)
  • Table 46. Asia Pacific Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 47. Asia Pacific Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 48. Asia Pacific Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 49. Asia Pacific Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 50. Asia Pacific Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 51. China Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 52. China Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 53. China Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 54. China Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 55. China Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 56. Japan Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 57. Japan Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 58. Japan Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 59. Japan Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 60. Japan Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 61. India Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 62. India Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 63. India Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 64. India Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 65. India Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 66. South Korea Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 67. South Korea Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 68. South Korea Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 69. South Korea Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 70. South Korea Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 71. Taiwan Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 72. Taiwan Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 73. Taiwan Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 74. Taiwan Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 75. Taiwan Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 76. Australia Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 77. Australia Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 78. Australia Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 79. Australia Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 80. Australia Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 81. Rest of Asia-Pacific Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 82. Rest of Asia-Pacific Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 83. Rest of Asia-Pacific Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 84. Rest of Asia-Pacific Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 85. Rest of Asia-Pacific Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 86. Europe Cannabidiol (CBD), by Country USD Million (2017-2022)
  • Table 87. Europe Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 88. Europe Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 89. Europe Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 90. Europe Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 91. Europe Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 92. Germany Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 93. Germany Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 94. Germany Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 95. Germany Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 96. Germany Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 97. France Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 98. France Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 99. France Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 100. France Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 101. France Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 102. Italy Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 103. Italy Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 104. Italy Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 105. Italy Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 106. Italy Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 107. United Kingdom Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 108. United Kingdom Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 109. United Kingdom Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 110. United Kingdom Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 111. United Kingdom Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 112. Netherlands Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 113. Netherlands Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 114. Netherlands Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 115. Netherlands Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 116. Netherlands Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 117. Rest of Europe Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 118. Rest of Europe Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 119. Rest of Europe Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 120. Rest of Europe Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 121. Rest of Europe Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 122. MEA Cannabidiol (CBD), by Country USD Million (2017-2022)
  • Table 123. MEA Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 124. MEA Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 125. MEA Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 126. MEA Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 127. MEA Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 128. Middle East Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 129. Middle East Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 130. Middle East Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 131. Middle East Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 132. Middle East Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 133. Africa Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 134. Africa Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 135. Africa Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 136. Africa Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 137. Africa Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 138. North America Cannabidiol (CBD), by Country USD Million (2017-2022)
  • Table 139. North America Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 140. North America Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 141. North America Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 142. North America Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 143. North America Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 144. United States Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 145. United States Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 146. United States Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 147. United States Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 148. United States Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 149. Canada Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 150. Canada Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 151. Canada Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 152. Canada Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 153. Canada Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 154. Mexico Cannabidiol (CBD), by Type USD Million (2017-2022)
  • Table 155. Mexico Cannabidiol (CBD), by Application USD Million (2017-2022)
  • Table 156. Mexico Cannabidiol (CBD), by Variants USD Million (2017-2022)
  • Table 157. Mexico Cannabidiol (CBD), by Distribution Channel USD Million (2017-2022)
  • Table 158. Mexico Cannabidiol (CBD), by Form USD Million (2017-2022)
  • Table 159. Cannabidiol (CBD) Sales: by Type(K Units)
  • Table 160. Cannabidiol (CBD) Sales Recreational , by Region K Units (2017-2022)
  • Table 161. Cannabidiol (CBD) Sales Medicinal , by Region K Units (2017-2022)
  • Table 162. Cannabidiol (CBD) Sales Synthetic. , by Region K Units (2017-2022)
  • Table 163. Cannabidiol (CBD) Sales: by Application(K Units)
  • Table 164. Cannabidiol (CBD) Sales CBD For Food & beverage , by Region K Units (2017-2022)
  • Table 165. Cannabidiol (CBD) Sales CBD Cosmetics & personal Care , by Region K Units (2017-2022)
  • Table 166. Cannabidiol (CBD) Sales CBD Pharmaceutical , by Region K Units (2017-2022)
  • Table 167. Cannabidiol (CBD) Sales Other , by Region K Units (2017-2022)
  • Table 168. Cannabidiol (CBD) Sales: by Variants(K Units)
  • Table 169. Cannabidiol (CBD) Sales Genus , by Region K Units (2017-2022)
  • Table 170. Cannabidiol (CBD) Sales Cannabis , by Region K Units (2017-2022)
  • Table 171. Cannabidiol (CBD) Sales Species , by Region K Units (2017-2022)
  • Table 172. Cannabidiol (CBD) Sales Strains , by Region K Units (2017-2022)
  • Table 173. Cannabidiol (CBD) Sales: by Distribution Channel(K Units)
  • Table 174. Cannabidiol (CBD) Sales Hospital Pharmacies , by Region K Units (2017-2022)
  • Table 175. Cannabidiol (CBD) Sales Retail Pharmacies , by Region K Units (2017-2022)
  • Table 176. Cannabidiol (CBD) Sales Online Stores , by Region K Units (2017-2022)
  • Table 177. Cannabidiol (CBD) Sales Others , by Region K Units (2017-2022)
  • Table 178. Cannabidiol (CBD) Sales: by Form(K Units)
  • Table 179. Cannabidiol (CBD) Sales CBD Processed Oil , by Region K Units (2017-2022)
  • Table 180. Cannabidiol (CBD) Sales CBD Distillate , by Region K Units (2017-2022)
  • Table 181. Cannabidiol (CBD) Sales CBD Isolated , by Region K Units (2017-2022)
  • Table 182. South America Cannabidiol (CBD) Sales, by Country K Units (2017-2022)
  • Table 183. South America Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 184. South America Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 185. South America Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 186. South America Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 187. South America Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 188. Brazil Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 189. Brazil Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 190. Brazil Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 191. Brazil Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 192. Brazil Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 193. Argentina Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 194. Argentina Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 195. Argentina Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 196. Argentina Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 197. Argentina Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 198. Rest of South America Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 199. Rest of South America Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 200. Rest of South America Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 201. Rest of South America Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 202. Rest of South America Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 203. Asia Pacific Cannabidiol (CBD) Sales, by Country K Units (2017-2022)
  • Table 204. Asia Pacific Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 205. Asia Pacific Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 206. Asia Pacific Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 207. Asia Pacific Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 208. Asia Pacific Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 209. China Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 210. China Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 211. China Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 212. China Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 213. China Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 214. Japan Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 215. Japan Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 216. Japan Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 217. Japan Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 218. Japan Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 219. India Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 220. India Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 221. India Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 222. India Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 223. India Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 224. South Korea Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 225. South Korea Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 226. South Korea Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 227. South Korea Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 228. South Korea Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 229. Taiwan Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 230. Taiwan Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 231. Taiwan Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 232. Taiwan Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 233. Taiwan Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 234. Australia Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 235. Australia Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 236. Australia Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 237. Australia Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 238. Australia Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 239. Rest of Asia-Pacific Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 240. Rest of Asia-Pacific Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 241. Rest of Asia-Pacific Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 242. Rest of Asia-Pacific Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 243. Rest of Asia-Pacific Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 244. Europe Cannabidiol (CBD) Sales, by Country K Units (2017-2022)
  • Table 245. Europe Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 246. Europe Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 247. Europe Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 248. Europe Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 249. Europe Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 250. Germany Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 251. Germany Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 252. Germany Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 253. Germany Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 254. Germany Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 255. France Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 256. France Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 257. France Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 258. France Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 259. France Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 260. Italy Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 261. Italy Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 262. Italy Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 263. Italy Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 264. Italy Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 265. United Kingdom Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 266. United Kingdom Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 267. United Kingdom Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 268. United Kingdom Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 269. United Kingdom Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 270. Netherlands Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 271. Netherlands Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 272. Netherlands Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 273. Netherlands Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 274. Netherlands Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 275. Rest of Europe Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 276. Rest of Europe Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 277. Rest of Europe Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 278. Rest of Europe Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 279. Rest of Europe Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 280. MEA Cannabidiol (CBD) Sales, by Country K Units (2017-2022)
  • Table 281. MEA Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 282. MEA Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 283. MEA Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 284. MEA Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 285. MEA Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 286. Middle East Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 287. Middle East Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 288. Middle East Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 289. Middle East Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 290. Middle East Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 291. Africa Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 292. Africa Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 293. Africa Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 294. Africa Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 295. Africa Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 296. North America Cannabidiol (CBD) Sales, by Country K Units (2017-2022)
  • Table 297. North America Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 298. North America Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 299. North America Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 300. North America Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 301. North America Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 302. United States Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 303. United States Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 304. United States Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 305. United States Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 306. United States Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 307. Canada Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 308. Canada Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 309. Canada Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 310. Canada Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 311. Canada Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 312. Mexico Cannabidiol (CBD) Sales, by Type K Units (2017-2022)
  • Table 313. Mexico Cannabidiol (CBD) Sales, by Application K Units (2017-2022)
  • Table 314. Mexico Cannabidiol (CBD) Sales, by Variants K Units (2017-2022)
  • Table 315. Mexico Cannabidiol (CBD) Sales, by Distribution Channel K Units (2017-2022)
  • Table 316. Mexico Cannabidiol (CBD) Sales, by Form K Units (2017-2022)
  • Table 317. Cannabidiol (CBD): by Type(USD/Units)
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. Company Basic Information, Sales Area and Its Competitors
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Company Basic Information, Sales Area and Its Competitors
  • Table 325. Company Basic Information, Sales Area and Its Competitors
  • Table 326. Company Basic Information, Sales Area and Its Competitors
  • Table 327. Company Basic Information, Sales Area and Its Competitors
  • Table 328. Cannabidiol (CBD): by Type(USD Million)
  • Table 329. Cannabidiol (CBD) Recreational , by Region USD Million (2023-2028)
  • Table 330. Cannabidiol (CBD) Medicinal , by Region USD Million (2023-2028)
  • Table 331. Cannabidiol (CBD) Synthetic. , by Region USD Million (2023-2028)
  • Table 332. Cannabidiol (CBD): by Application(USD Million)
  • Table 333. Cannabidiol (CBD) CBD For Food & beverage , by Region USD Million (2023-2028)
  • Table 334. Cannabidiol (CBD) CBD Cosmetics & personal Care , by Region USD Million (2023-2028)
  • Table 335. Cannabidiol (CBD) CBD Pharmaceutical , by Region USD Million (2023-2028)
  • Table 336. Cannabidiol (CBD) Other , by Region USD Million (2023-2028)
  • Table 337. Cannabidiol (CBD): by Variants(USD Million)
  • Table 338. Cannabidiol (CBD) Genus , by Region USD Million (2023-2028)
  • Table 339. Cannabidiol (CBD) Cannabis , by Region USD Million (2023-2028)
  • Table 340. Cannabidiol (CBD) Species , by Region USD Million (2023-2028)
  • Table 341. Cannabidiol (CBD) Strains , by Region USD Million (2023-2028)
  • Table 342. Cannabidiol (CBD): by Distribution Channel(USD Million)
  • Table 343. Cannabidiol (CBD) Hospital Pharmacies , by Region USD Million (2023-2028)
  • Table 344. Cannabidiol (CBD) Retail Pharmacies , by Region USD Million (2023-2028)
  • Table 345. Cannabidiol (CBD) Online Stores , by Region USD Million (2023-2028)
  • Table 346. Cannabidiol (CBD) Others , by Region USD Million (2023-2028)
  • Table 347. Cannabidiol (CBD): by Form(USD Million)
  • Table 348. Cannabidiol (CBD) CBD Processed Oil , by Region USD Million (2023-2028)
  • Table 349. Cannabidiol (CBD) CBD Distillate , by Region USD Million (2023-2028)
  • Table 350. Cannabidiol (CBD) CBD Isolated , by Region USD Million (2023-2028)
  • Table 351. South America Cannabidiol (CBD), by Country USD Million (2023-2028)
  • Table 352. South America Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 353. South America Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 354. South America Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 355. South America Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 356. South America Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 357. Brazil Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 358. Brazil Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 359. Brazil Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 360. Brazil Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 361. Brazil Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 362. Argentina Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 363. Argentina Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 364. Argentina Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 365. Argentina Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 366. Argentina Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 367. Rest of South America Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 368. Rest of South America Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 369. Rest of South America Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 370. Rest of South America Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 371. Rest of South America Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 372. Asia Pacific Cannabidiol (CBD), by Country USD Million (2023-2028)
  • Table 373. Asia Pacific Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 374. Asia Pacific Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 375. Asia Pacific Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 376. Asia Pacific Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 377. Asia Pacific Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 378. China Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 379. China Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 380. China Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 381. China Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 382. China Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 383. Japan Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 384. Japan Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 385. Japan Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 386. Japan Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 387. Japan Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 388. India Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 389. India Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 390. India Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 391. India Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 392. India Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 393. South Korea Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 394. South Korea Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 395. South Korea Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 396. South Korea Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 397. South Korea Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 398. Taiwan Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 399. Taiwan Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 400. Taiwan Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 401. Taiwan Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 402. Taiwan Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 403. Australia Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 404. Australia Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 405. Australia Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 406. Australia Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 407. Australia Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 408. Rest of Asia-Pacific Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 409. Rest of Asia-Pacific Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 410. Rest of Asia-Pacific Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 411. Rest of Asia-Pacific Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 412. Rest of Asia-Pacific Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 413. Europe Cannabidiol (CBD), by Country USD Million (2023-2028)
  • Table 414. Europe Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 415. Europe Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 416. Europe Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 417. Europe Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 418. Europe Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 419. Germany Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 420. Germany Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 421. Germany Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 422. Germany Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 423. Germany Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 424. France Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 425. France Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 426. France Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 427. France Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 428. France Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 429. Italy Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 430. Italy Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 431. Italy Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 432. Italy Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 433. Italy Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 434. United Kingdom Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 435. United Kingdom Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 436. United Kingdom Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 437. United Kingdom Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 438. United Kingdom Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 439. Netherlands Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 440. Netherlands Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 441. Netherlands Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 442. Netherlands Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 443. Netherlands Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 444. Rest of Europe Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 445. Rest of Europe Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 446. Rest of Europe Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 447. Rest of Europe Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 448. Rest of Europe Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 449. MEA Cannabidiol (CBD), by Country USD Million (2023-2028)
  • Table 450. MEA Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 451. MEA Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 452. MEA Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 453. MEA Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 454. MEA Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 455. Middle East Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 456. Middle East Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 457. Middle East Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 458. Middle East Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 459. Middle East Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 460. Africa Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 461. Africa Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 462. Africa Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 463. Africa Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 464. Africa Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 465. North America Cannabidiol (CBD), by Country USD Million (2023-2028)
  • Table 466. North America Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 467. North America Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 468. North America Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 469. North America Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 470. North America Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 471. United States Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 472. United States Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 473. United States Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 474. United States Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 475. United States Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 476. Canada Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 477. Canada Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 478. Canada Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 479. Canada Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 480. Canada Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 481. Mexico Cannabidiol (CBD), by Type USD Million (2023-2028)
  • Table 482. Mexico Cannabidiol (CBD), by Application USD Million (2023-2028)
  • Table 483. Mexico Cannabidiol (CBD), by Variants USD Million (2023-2028)
  • Table 484. Mexico Cannabidiol (CBD), by Distribution Channel USD Million (2023-2028)
  • Table 485. Mexico Cannabidiol (CBD), by Form USD Million (2023-2028)
  • Table 486. Cannabidiol (CBD) Sales: by Type(K Units)
  • Table 487. Cannabidiol (CBD) Sales Recreational , by Region K Units (2023-2028)
  • Table 488. Cannabidiol (CBD) Sales Medicinal , by Region K Units (2023-2028)
  • Table 489. Cannabidiol (CBD) Sales Synthetic. , by Region K Units (2023-2028)
  • Table 490. Cannabidiol (CBD) Sales: by Application(K Units)
  • Table 491. Cannabidiol (CBD) Sales CBD For Food & beverage , by Region K Units (2023-2028)
  • Table 492. Cannabidiol (CBD) Sales CBD Cosmetics & personal Care , by Region K Units (2023-2028)
  • Table 493. Cannabidiol (CBD) Sales CBD Pharmaceutical , by Region K Units (2023-2028)
  • Table 494. Cannabidiol (CBD) Sales Other , by Region K Units (2023-2028)
  • Table 495. Cannabidiol (CBD) Sales: by Variants(K Units)
  • Table 496. Cannabidiol (CBD) Sales Genus , by Region K Units (2023-2028)
  • Table 497. Cannabidiol (CBD) Sales Cannabis , by Region K Units (2023-2028)
  • Table 498. Cannabidiol (CBD) Sales Species , by Region K Units (2023-2028)
  • Table 499. Cannabidiol (CBD) Sales Strains , by Region K Units (2023-2028)
  • Table 500. Cannabidiol (CBD) Sales: by Distribution Channel(K Units)
  • Table 501. Cannabidiol (CBD) Sales Hospital Pharmacies , by Region K Units (2023-2028)
  • Table 502. Cannabidiol (CBD) Sales Retail Pharmacies , by Region K Units (2023-2028)
  • Table 503. Cannabidiol (CBD) Sales Online Stores , by Region K Units (2023-2028)
  • Table 504. Cannabidiol (CBD) Sales Others , by Region K Units (2023-2028)
  • Table 505. Cannabidiol (CBD) Sales: by Form(K Units)
  • Table 506. Cannabidiol (CBD) Sales CBD Processed Oil , by Region K Units (2023-2028)
  • Table 507. Cannabidiol (CBD) Sales CBD Distillate , by Region K Units (2023-2028)
  • Table 508. Cannabidiol (CBD) Sales CBD Isolated , by Region K Units (2023-2028)
  • Table 509. South America Cannabidiol (CBD) Sales, by Country K Units (2023-2028)
  • Table 510. South America Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 511. South America Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 512. South America Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 513. South America Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 514. South America Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 515. Brazil Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 516. Brazil Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 517. Brazil Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 518. Brazil Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 519. Brazil Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 520. Argentina Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 521. Argentina Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 522. Argentina Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 523. Argentina Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 524. Argentina Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 525. Rest of South America Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 526. Rest of South America Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 527. Rest of South America Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 528. Rest of South America Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 529. Rest of South America Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 530. Asia Pacific Cannabidiol (CBD) Sales, by Country K Units (2023-2028)
  • Table 531. Asia Pacific Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 532. Asia Pacific Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 533. Asia Pacific Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 534. Asia Pacific Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 535. Asia Pacific Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 536. China Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 537. China Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 538. China Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 539. China Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 540. China Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 541. Japan Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 542. Japan Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 543. Japan Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 544. Japan Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 545. Japan Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 546. India Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 547. India Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 548. India Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 549. India Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 550. India Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 551. South Korea Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 552. South Korea Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 553. South Korea Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 554. South Korea Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 555. South Korea Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 556. Taiwan Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 557. Taiwan Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 558. Taiwan Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 559. Taiwan Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 560. Taiwan Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 561. Australia Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 562. Australia Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 563. Australia Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 564. Australia Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 565. Australia Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 566. Rest of Asia-Pacific Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 567. Rest of Asia-Pacific Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 568. Rest of Asia-Pacific Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 569. Rest of Asia-Pacific Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 570. Rest of Asia-Pacific Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 571. Europe Cannabidiol (CBD) Sales, by Country K Units (2023-2028)
  • Table 572. Europe Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 573. Europe Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 574. Europe Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 575. Europe Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 576. Europe Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 577. Germany Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 578. Germany Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 579. Germany Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 580. Germany Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 581. Germany Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 582. France Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 583. France Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 584. France Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 585. France Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 586. France Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 587. Italy Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 588. Italy Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 589. Italy Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 590. Italy Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 591. Italy Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 592. United Kingdom Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 593. United Kingdom Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 594. United Kingdom Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 595. United Kingdom Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 596. United Kingdom Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 597. Netherlands Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 598. Netherlands Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 599. Netherlands Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 600. Netherlands Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 601. Netherlands Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 602. Rest of Europe Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 603. Rest of Europe Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 604. Rest of Europe Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 605. Rest of Europe Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 606. Rest of Europe Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 607. MEA Cannabidiol (CBD) Sales, by Country K Units (2023-2028)
  • Table 608. MEA Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 609. MEA Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 610. MEA Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 611. MEA Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 612. MEA Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 613. Middle East Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 614. Middle East Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 615. Middle East Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 616. Middle East Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 617. Middle East Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 618. Africa Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 619. Africa Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 620. Africa Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 621. Africa Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 622. Africa Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 623. North America Cannabidiol (CBD) Sales, by Country K Units (2023-2028)
  • Table 624. North America Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 625. North America Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 626. North America Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 627. North America Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 628. North America Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 629. United States Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 630. United States Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 631. United States Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 632. United States Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 633. United States Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 634. Canada Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 635. Canada Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 636. Canada Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 637. Canada Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 638. Canada Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 639. Mexico Cannabidiol (CBD) Sales, by Type K Units (2023-2028)
  • Table 640. Mexico Cannabidiol (CBD) Sales, by Application K Units (2023-2028)
  • Table 641. Mexico Cannabidiol (CBD) Sales, by Variants K Units (2023-2028)
  • Table 642. Mexico Cannabidiol (CBD) Sales, by Distribution Channel K Units (2023-2028)
  • Table 643. Mexico Cannabidiol (CBD) Sales, by Form K Units (2023-2028)
  • Table 644. Cannabidiol (CBD): by Type(USD/Units)
  • Table 645. Research Programs/Design for This Report
  • Table 646. Key Data Information from Secondary Sources
  • Table 647. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cannabidiol (CBD): by Type USD Million (2017-2022)
  • Figure 5. Global Cannabidiol (CBD): by Application USD Million (2017-2022)
  • Figure 6. Global Cannabidiol (CBD): by Variants USD Million (2017-2022)
  • Figure 7. Global Cannabidiol (CBD): by Distribution Channel USD Million (2017-2022)
  • Figure 8. Global Cannabidiol (CBD): by Form USD Million (2017-2022)
  • Figure 9. South America Cannabidiol (CBD) Share (%), by Country
  • Figure 10. Asia Pacific Cannabidiol (CBD) Share (%), by Country
  • Figure 11. Europe Cannabidiol (CBD) Share (%), by Country
  • Figure 12. MEA Cannabidiol (CBD) Share (%), by Country
  • Figure 13. North America Cannabidiol (CBD) Share (%), by Country
  • Figure 14. Global Cannabidiol (CBD): by Type K Units (2017-2022)
  • Figure 15. Global Cannabidiol (CBD): by Application K Units (2017-2022)
  • Figure 16. Global Cannabidiol (CBD): by Variants K Units (2017-2022)
  • Figure 17. Global Cannabidiol (CBD): by Distribution Channel K Units (2017-2022)
  • Figure 18. Global Cannabidiol (CBD): by Form K Units (2017-2022)
  • Figure 19. South America Cannabidiol (CBD) Share (%), by Country
  • Figure 20. Asia Pacific Cannabidiol (CBD) Share (%), by Country
  • Figure 21. Europe Cannabidiol (CBD) Share (%), by Country
  • Figure 22. MEA Cannabidiol (CBD) Share (%), by Country
  • Figure 23. North America Cannabidiol (CBD) Share (%), by Country
  • Figure 24. Global Cannabidiol (CBD): by Type USD/Units (2017-2022)
  • Figure 25. Global Cannabidiol (CBD) share by Players 2022 (%)
  • Figure 26. Global Cannabidiol (CBD) share by Players (Top 3) 2022(%)
  • Figure 27. Global Cannabidiol (CBD) share by Players (Top 5) 2022(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. INSYS Therapeutics, INC (United States) Revenue, Net Income and Gross profit
  • Figure 30. INSYS Therapeutics, INC (United States) Revenue: by Geography 2022
  • Figure 31. EPIDOLEX (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. EPIDOLEX (United Kingdom) Revenue: by Geography 2022
  • Figure 33. Night food holding (United States) Revenue, Net Income and Gross profit
  • Figure 34. Night food holding (United States) Revenue: by Geography 2022
  • Figure 35. Pivot pharmaceuticals INC (Canada) Revenue, Net Income and Gross profit
  • Figure 36. Pivot pharmaceuticals INC (Canada) Revenue: by Geography 2022
  • Figure 37. Marijuana company of America (United States) Revenue, Net Income and Gross profit
  • Figure 38. Marijuana company of America (United States) Revenue: by Geography 2022
  • Figure 39. ENDOCA (United States) Revenue, Net Income and Gross profit
  • Figure 40. ENDOCA (United States) Revenue: by Geography 2022
  • Figure 41. Cannoid, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 42. Cannoid, LLC (United States) Revenue: by Geography 2022
  • Figure 43. Folium Biosciences (United States) Revenue, Net Income and Gross profit
  • Figure 44. Folium Biosciences (United States) Revenue: by Geography 2022
  • Figure 45. Elixinol (United States) Revenue, Net Income and Gross profit
  • Figure 46. Elixinol (United States) Revenue: by Geography 2022
  • Figure 47. NuLeaf Naturals, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 48. NuLeaf Naturals, LLC (United States) Revenue: by Geography 2022
  • Figure 49. Global Cannabidiol (CBD): by Type USD Million (2023-2028)
  • Figure 50. Global Cannabidiol (CBD): by Application USD Million (2023-2028)
  • Figure 51. Global Cannabidiol (CBD): by Variants USD Million (2023-2028)
  • Figure 52. Global Cannabidiol (CBD): by Distribution Channel USD Million (2023-2028)
  • Figure 53. Global Cannabidiol (CBD): by Form USD Million (2023-2028)
  • Figure 54. South America Cannabidiol (CBD) Share (%), by Country
  • Figure 55. Asia Pacific Cannabidiol (CBD) Share (%), by Country
  • Figure 56. Europe Cannabidiol (CBD) Share (%), by Country
  • Figure 57. MEA Cannabidiol (CBD) Share (%), by Country
  • Figure 58. North America Cannabidiol (CBD) Share (%), by Country
  • Figure 59. Global Cannabidiol (CBD): by Type K Units (2023-2028)
  • Figure 60. Global Cannabidiol (CBD): by Application K Units (2023-2028)
  • Figure 61. Global Cannabidiol (CBD): by Variants K Units (2023-2028)
  • Figure 62. Global Cannabidiol (CBD): by Distribution Channel K Units (2023-2028)
  • Figure 63. Global Cannabidiol (CBD): by Form K Units (2023-2028)
  • Figure 64. South America Cannabidiol (CBD) Share (%), by Country
  • Figure 65. Asia Pacific Cannabidiol (CBD) Share (%), by Country
  • Figure 66. Europe Cannabidiol (CBD) Share (%), by Country
  • Figure 67. MEA Cannabidiol (CBD) Share (%), by Country
  • Figure 68. North America Cannabidiol (CBD) Share (%), by Country
  • Figure 69. Global Cannabidiol (CBD): by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • INSYS Therapeutics, INC (United States)
  • EPIDOLEX (United Kingdom)
  • Night food holding (United States)
  • pivot pharmaceuticals INC (Canada)
  • marijuana company of America (United States)
  • ENDOCA (United States)
  • Cannoid, LLC (United States)
  • Folium Biosciences (United States)
  • Elixinol (United States)
  • NuLeaf Naturals, LLC (United States)
Select User Access Type

Key Highlights of Report


Apr 2023 217 Pages 93 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Cannabidiol (CBD) Quantitative research analysis
Global Cannabidiol (CBD) Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global Cannabidiol (CBD) market are INSYS Therapeutics, INC (United States), EPIDOLEX (United Kingdom), Night food holding (United States), pivot pharmaceuticals INC (Canada), marijuana company of America (United States), ENDOCA (United States), Cannoid, LLC (United States), Folium Biosciences (United States), Elixinol (United States) and NuLeaf Naturals, LLC (United States).
In this highly competitive & fast evolving Cannabidiol (CBD) industry, the top strategic priorities would remain consistent like innovation, R&D, and M&A.
CBD For Food & beverage, CBD Cosmetics & personal Care, CBD Pharmaceutical and Other are the potential customers of Cannabidiol (CBD) industry.

Know More About Global Cannabidiol (CBD) Report?

Have a Query? Click Here

Other Related Reports

Dalbavancin Comprehensive Study by Type (Intravenous Therapy, Oral Type), Application (Skin Infection, Soft Tissue Infection, Others), End Users (Hospitals and clinics, Chemical firms, API demanding ...
$ 3650
Pharmaceutical Cold Chain Logistics Comprehensive Study by Application (Pharmaceuticals, CRO, Others), Drug Supply Stage (Outsourced, In-house), Service (Transportation (Type (Sea freight, Airfreight...
$ 3750
Recombinant Human Serum Albumins Comprehensive Study by Type (OsrHSA, ScrHSA), Application (Drug Formulation, Pharmaceuticals, Diagnostics, Coating of Medical Devices, Vitro Fertilization, Cosmetic, ...
$ 3450
Naproxen Comprehensive Study by Type (Tablet, Capsule, Other), Application (Rheumatoid Arthritis, Gout, Other), Distribution Channels (Pharmaceutical Stores, Clinics, Others) Players and Region - Glo...
$ 3500
Erythromycin Comprehensive Study by Form (Gel, Tablet, Topical Solution, Ointment, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Therapeutic Indications (...
$ 3650
Dystonia Drugs Comprehensive Study by Route of Administration (Oral, Injectable), Drug Types (Capsules, Tablets, Other), Dystonias syndromes (Blepharospasm, Cervical dystonia, Cranial dystonia, Tardi...
$ 3750